Skip to main content
Equibles

Caroline Baumal, M.D.

Apellis Pharmaceuticals, Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Caroline Baumal, M.D.

Apellis Pharmaceuticals, Inc. reported in an 8-K filed January 5, 2023 that Caroline Baumal, M.D. was appointed Chief Medical Officer, effective January 3, 2023.

“the Company also announced that Caroline Baumal, M.D. will join the Company as Chief Medical Officer, effective as of January 3, 2023.”
Apellis Pharmaceuticals, Inc. Form 8-K, filed January 5, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Apellis Pharmaceuticals, Inc.

    SEC 8-K

    Current

    2023-01-03–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Apellis Pharmaceuticals, Inc.

Current role

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.